From: Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis
Bilirubin >8 mg/dL
Ascites
Number of patients
30-day Mortality
Yes
6
83%
No
2
0%
11
18%
15